Natus Medical reported $14.57M in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abiomed ABMD:US $ 67.4M 15.29M
Accuray ARAY:US $ 3.83M 1.81M
Atricure ATRC:US $ 183.8M 196.22M
Boston Scientific BSX:US $ 477M 362M
Cardiovascular Systems CSII:US $ -6.86M 3.12M
Cooper Companies COO:US $ 164.7M 16M
General Electric GE:US $ 1614M 85M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Globus Medical GMED:US $ 71.05M 7.83M
Hill Rom HRC:US $ 181.6M 26.5M
Inogen INGN:US $ 11.79M 11M
Insulet PODD:US $ 48.2M 6.7M
Integra Lifesciences IART:US $ 104.32M 3.32M
Koninklijke Philips PHG:US 754M 29M
Masimo MASI:US $ 76.81M 2.88M
Medtronic MDT:US $ 2283M 268M
Mesa Laboratories MLAB:US $ 8.48M 783K
Natus Medical BABY:US $ 14.57M 1.25M
Orthofix International OFIX:US $ 7.32M 5.01M
Perkinelmer PKI:US $ 375.02M 48.76M
Philips PHIA:NA € 754M 29M
Surmodics SRDX:US $ 2.51M 2.58M
Tandem Diabetes Care TNDM:US $ 11.12M 2.25M
Thermo Fisher Scientific TMO:US $ 2924M 24M
Trinity Biotech TRIB:US 7.09M 3.21M